Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Black Diamond Therapeutics (BDTX) Return on Assets (2020 - 2025)

Black Diamond Therapeutics' Return on Assets history spans 4 years, with the latest figure at 0.11% for Q4 2025.

  • For Q4 2025, Return on Assets rose 70.0% year-over-year to 0.11%; the TTM value through Dec 2025 reached 0.11%, up 70.0%, while the annual FY2025 figure was 0.12%, N/A changed from the prior year.
  • Return on Assets reached 0.11% in Q4 2025 per BDTX's latest filing, up from 0.09% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.11% in Q4 2025 to a low of 0.75% in Q2 2024.
  • Average Return on Assets over 3 years is 0.3%, with a median of 0.34% recorded in 2021.
  • Peak YoY movement for Return on Assets: dropped -27bps in 2021, then surged 79bps in 2025.
  • A 3-year view of Return on Assets shows it stood at 0.43% in 2021, then crashed by -38bps to 0.59% in 2024, then soared by 119bps to 0.11% in 2025.
  • Per Business Quant, the three most recent readings for BDTX's Return on Assets are 0.11% (Q4 2025), 0.09% (Q3 2025), and 0.04% (Q2 2025).